Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Khan, A; Ostaku, J; Aras, E; Safak, Seker, UO.
Combating Infectious Diseases with Synthetic Biology.
ACS Synth Biol. 2022; 11(2): 528-537.
Doi: 10.1021/acssynbio.1c00576
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Ostaku Julian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Over the past decades, there have been numerous outbreaks, including parasitic, fungal, bacterial, and viral infections, worldwide. The rate at which infectious diseases are emerging is disproportionate to the rate of development for new strategies that could combat them. Therefore, there is an increasing demand to develop novel, specific, sensitive, and effective methods for infectious disease diagnosis and treatment. Designed synthetic systems and devices are becoming powerful tools to treat human diseases. The advancement in synthetic biology offers efficient, accurate, and cost-effective platforms for detecting and preventing infectious diseases. Herein we focus on the latest state of living theranostics and its implications.
- Find related publications in this database (using NLM MeSH Indexing)
-
Bacterial Physiological Phenomena - administration & dosage
-
Bacteriophages - genetics
-
COVID-19 - therapy, virology
-
Communicable Disease Control - methods
-
Humans - administration & dosage
-
Pandemics - administration & dosage
-
Precision Medicine - administration & dosage
-
SARS-CoV-2 - isolation & purification, pathogenicity
-
Synthetic Biology - administration & dosage
- Find related publications in this database (Keywords)
-
synthetic biology
-
infectious diseases
-
engineered phage and bacteria
-
SARS-CoV-2
-
diagnostics
-
therapeutics